FIELD: medicine.
SUBSTANCE: invention refers to a combination, such as a combined preparation or a pharmaceutical composition for prevention and delay of progressing or treatment of diabetes and diabetes associated diseases and conditions in mammals, containing at least one cis-polyunsaturated fatty acid, at least one amino acid and, at least one diabetic agent for prevention, delay of progressing or treatment of diabetes type 2 and diabetes associated diseases or conditions. Method of weight reduction in mammals involves oral introduction of the combination in effective metabolism-changing amount and glucose; and repeated introduction of the specified amount.
EFFECT: higher duration of effect, wide spectrum of therapeutic action, higher glucose clearance after insulin introduction, higher triglyceride clearance, lower dosage of individual medicines and reduced rate of preparation dose.
18 cl, 10 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
NOVEL FATTY ACID ANALOGS FOR TREATMENT OF DIABETES | 1999 |
|
RU2221558C2 |
FOOD PRODUCT FOR DIABETICS | 2005 |
|
RU2380983C2 |
PANCREATIC DIABETES DRUG | 2004 |
|
RU2358738C2 |
COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2004 |
|
RU2367423C2 |
METHOD FOR TREATING DIABETES | 2003 |
|
RU2320343C2 |
METHOD OF DIABETES TREATMENT | 2007 |
|
RU2442585C2 |
COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
TREATING DIABETES AND METABOLIC SYNDROME | 2010 |
|
RU2537181C2 |
COMPOSITION FOR TREATMENT OF DIABETES MELLITUS | 2016 |
|
RU2679602C1 |
Authors
Dates
2009-05-27—Published
2004-02-23—Filed